Events2Join

Antibacterial pipeline trends and recommendations to enhance ...


Antibacterial pipeline trends and recommendations to enhance ...

Publicaciones de la Organización Mundial de la Salud.

Antibacterial pipeline trends and recommendations to enhance ...

The World Health Organization (WHO) policy brief, "Antibacterial pipeline trends and recommendations to enhance research and development" provides ...

Antibacterial pipeline trends and recommendations to enhance ...

The World Health Organization (WHO) policy brief, “Antibacterial pipeline trends and recommendations to enhance research and development,” ...

Multi-year analysis of the global preclinical antibacterial pipeline

The review identifies potential new classes of antibiotics or novel mechanisms of action that can better address resistant bacterial strains.

Valeria Gigante on LinkedIn: Antibacterial pipeline trends and ...

Valeria Gigante's Post · Antibacterial pipeline trends and recommendations to enhance research and development: policy brief · More Relevant Posts.

WHO Antibacterial Pipeline Review: Update thru 31 Dec 2023

Based on these summaries, you will not be surprised by the report's sobering main conclusion: “Overall, antibacterial agents in the clinical ...

insights from WHO 2023 antibacterial clinical pipeline analyses

The analysis emphasises the remaining gaps in developing a robust and effective antibacterial drug pipeline, drawing insights from trend ...

Antibiotics in the clinical pipeline as of December 2022 - PMC

The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clearly attracted global attention ...

Antibiotics in the clinical pipeline as of December 2022 - Nature

The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clearly attracted ...

WHO calls for coordinated effort to boost antibiotic development

The WHO notes that of the 128 antibacterial agents in the development pipeline over the past 6 years, only 16 have received market approval, and ...

WHO: AMR Policy Brief and Preclinical pipeline data call • AMR ...

A policy brief on AMR entitled: Antibacterial pipeline trends and recommendations to enhance research and development.

Manica Balasegaram on X: "Antibacterial pipeline trends and ...

Antibacterial pipeline trends and recommendations to enhance research and development https://who.int/publications/i/item/9789240097735… 5 ...

Combating Antimicrobial Resistance: Policy Recommendations to ...

1. Clear and feasible regulatory guidelines on clinical trial designs are urgently needed to enable approvals of new antibiotics and other antimicrobials. In ...

The global preclinical antibacterial pipeline - JPIAMR

There is also a strong trend towards non- traditional approaches, including diverse antivirulence approaches, microbiome- modifying strategies, and engineered ...

Antibiotic Development: The 10 x '20 Initiative - IDSA

New antibiotics are desperately needed to save patients' lives, but few new drugs are in pharmaceutical companies' research and development (R&D) pipelines. Low ...

The Antibacterial Research and Development Pipeline Needs ...

The two new reports released by the World Health Organization on the preclinical and clinical antibacterial pipeline show that the current ...

Towards the sustainable discovery and development of new antibiotics

To ensure a healthy and vibrant antimicrobial pipeline, considerable efforts are needed not only to develop the next generation of antibacterial ...

Tracking the Global Pipeline of Antibiotics in Development, March ...

To ensure that the supply of new antibiotics keeps pace with these evolving pathogens, it is necessary to have a robust pipeline of new drugs—as ...

Exploring the Global Clinical and Preclinical Antibacterial Pipelines

According to the WHO report published in 2021, the global clinical pipeline currently includes 43 conventional antibiotics and 27 non- ...

Trends in Antimicrobial Drug Development: Implications for the Future

The need for new antimicrobial agents is greater than ever because of the emergence of multidrug resistance in common pathogens, the rapid emergence of new ...